3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Status
Completed
15
Unknown
5
Recruiting
3
Active not recruiting
3
Terminated
2
Not yet recruiting
2
Withdrawn
1
Enrolling by invitation
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
2
Genitourinary
1
Conditions
Motor Activity
3
Breast Neoplasms
3
Neoplasms
2
Triple Negative Breast Neoplasms
1
Sarcopenia
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Obesity
1
Neoplasm Metastasis
1
Hematopoietic and Lymphatic System Neoplasm
1
Fatigue
1
Cholangiocarcinoma
1
Interventions
Exercise
22
Surveys and Questionnaires
3
Resistance Training
3
Diet
3
Control Groups
3
Nutrition Assessment
2
Methods
2
Interviews as Topic
2
High-Intensity Interval Training
2
Exercise Therapy
2
Counseling
2
pertuzumab
1
pembrolizumab
1
cytisine
1
cemiplimab
1
avelumab
1
Weights and Measures
1
Trastuzumab
1
Therapeutics
1
Telemedicine
1
Standard of Care
1
Spirometry
1
Rehabilitation
1
Psychiatric Rehabilitation
1
Palliative Care
1
Paclitaxel
1
Nivolumab
1
Neoadjuvant Therapy
1
Ipilimumab
1
Immune Checkpoint Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Active not recruiting
×
Motor Activity
×
Resistance Training
×
Clear all
NCT02999074
2024-12-11
BENEFIT
German Cancer Research Center
Phase NA
Active not recruiting
183 enrolled
NCT02730338
2024-11-27
INTERVAL
Movember Foundation
Phase NA
Active not recruiting
866 enrolled
NCT06618690
2024-10-01
IO/2024
Universidad de Burgos
Phase NA
Active not recruiting
325 enrolled